Workflow
我武生物2025年上半年净利润同比增长18.61%

Core Viewpoint - Iwubio announced a revenue of 484 million yuan for the first half of 2025, representing a year-on-year growth of 12.81% [1] - The net profit attributable to shareholders reached 177 million yuan, with a year-on-year increase of 18.61% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 173 million yuan, showing a year-on-year growth of 21.97% [1] Financial Performance - Revenue for the first half of 2025: 484 million yuan, up 12.81% year-on-year [1] - Net profit attributable to shareholders: 177 million yuan, up 18.61% year-on-year [1] - Net profit after deducting non-recurring gains and losses: 173 million yuan, up 21.97% year-on-year [1]